tiprankstipranks
Dawnrays Pharmaceutical Holdings Ltd. (HK:2348)
:2348
Hong Kong Market
2348
Dawnrays Pharmaceutical Holdings Ltd.
RESEARCH TOOLSreports
Want to see HK:2348 full AI Analyst Report?

Dawnrays Pharmaceutical Holdings Ltd. (2348) Income Statement

5 Followers

Dawnrays Pharmaceutical Holdings Ltd. Income Statement

Last quarter (Q4 2025), Dawnrays Pharmaceutical Holdings Ltd.'s total revenue was ¥600.44M, an increase of 19.80% from the same quarter last year. In Q4, Dawnrays Pharmaceutical Holdings Ltd.'s net income was ¥109.40M. See Dawnrays Pharmaceutical Holdings Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
¥ 1.23B¥ 1.06B¥ 1.15B¥ 1.28B¥ 1.17B
Gross Profit
¥ 557.40M¥ 577.63M¥ 641.52M¥ 766.68M¥ 675.36M
Operating Expenses
¥ 327.75M¥ 209.72M¥ 199.20M¥ 344.27M¥ 293.47M
Depreciation and Amortization
¥ 116.23M¥ 78.44M¥ 83.89M¥ 66.41M¥ 53.13M
EBITDA
¥ 343.66M¥ 280.49M¥ 498.94M¥ 505.19M¥ 433.89M
Operating Income
¥ 229.65M¥ 367.91M¥ 277.42M¥ 422.41M¥ 380.76M
Other Income/Expenses
¥ 19.96M¥ 269.04M¥ 136.64M¥ 16.00M¥ 57.43M
Pretax Income
¥ 249.61M¥ 636.95M¥ 414.06M¥ 438.41M¥ 439.32M
Net Income
¥ 213.97M¥ 564.94M¥ 326.00M¥ 358.06M¥ 358.18M
Per Share Metrics
Basic EPS
¥ 0.14¥ 0.38¥ 0.22¥ 0.24¥ 0.24
Diluted EPS
¥ 0.14¥ 0.38¥ 0.22¥ 0.24¥ 0.24
Weighted Average Shares Outstanding
 1.53B 1.51B 1.50B 1.50B 1.50B
Weighted Average Shares Outstanding (Diluted)
 1.50B 1.51B 1.50B 1.50B 1.51B
Currency in CNY

Dawnrays Pharmaceutical Holdings Ltd. Earnings and Revenue History